InMed Pharmaceuticals Inc (INM) stock is lower by -83.66% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives INM stock a score of 35 out of a possible 100.
That rank is mainly influenced by a long-term technical score of 2. INM's rank also includes a short-term technical score of 30.
INM has an Overall Score of 35. Find out what this means to you and get the rest of the rankings on INM!
InMed Pharmaceuticals Inc (INM) stock is down -8.2% while the S&P 500 has risen 0.05% as of 12:22 PM on Monday, Nov 6. INM is lower by -$0.04 from the previous closing price of $0.46 on volume of 178,375 shares. Over the past year the S&P 500 has risen 14.55% while INM is lower by -83.66%. INM lost -$3.25 per share in the over the last 12 months.
Click Here to get the full Stock Report for InMed Pharmaceuticals Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
